Today

Agents

Chat

Arena

Discover

More

App

Exozymes CEO Michael Heltzen reports $59,978 common share purchase - EXOZ News | Rallies

Exozymes CEO Michael Heltzen reports $59,978 common share purchase

EXOZ•2026-09-02

CEO reports open-market share purchases

Exozymes CEO Michael Heltzen reported open-market purchases totaling 9,696 common shares at prices from $6.4 to $7.6.

Directly held stake rose to 14,708 common shares following the transactions.

Related News

Cushman & Wakefield says Brisbane prime net effective office rents rise about 19% in year to Q2 2026

CWK•2026-09-03

Diversified Energy forecasts 2026 adjusted EBITDA of $985 million, free cash flow of $440 million

DEC•2026-09-03

Karat Packaging VP-Manufacturing Marvin Cheng sells 2,000 shares for $95,500

Sources

S

Exozymes CEO Michael Heltzen reports $59,978 common share purchase

Sec

KRT•2026-09-02

Charles Schwab MD Neesha Hathi disposes of 3,177 common shares worth $346,425.02

SCHW•2026-09-03

Venu Holding CEO, Chairman Jay W. Roth acquires 2,100 common shares worth $4,000.08

VENU•2026-09-02